Chronic Obstructive Pulmonary Disease (COPD) and the Impact of COVID-19 Make an Appointment Ask a Question Search Conditions Saving and improving the lives of the millions who suffer from COPD is the goal of the physicians and scientists at National Jewish Health. Leading the largest study in the world, COPDGene ®, we are on track to stop the progression of this fatal disease. Barry J. Make, MD, and Anthony N. Gerber, MD, PhD will share where we are in the process and how the COVID-19 virus impacts COPD patients and their treatment. To sign up for future Dialogue with a Doc discussions, please visit njhealth.org/DocSeries Related Videos COVID-19 and Respiratory Illness: A Research & Treatment Update Asthma Research & Treatment and COVID-19 Advancements in Childhood and Adult Allergy Research and Treatment Cardiology and the Impact of COVID-19: The Link Between the Heart and the Lung Nontuberculous Mycobacteria (NTM), Bronchiectasis and COVID-19: Research and Treatment Update Autoimmune Diseases, the Impact of COVID-19 and Vaccine Development Gastroenterology: The Gut, the Lung and Beyond Heart Health: Prevention, Lifestyle and Wellness Interstitial Lung Disease (ILD) and Idiopathic Pulmonary Fibrosis (IPF) Exercise Intolerance: Breathing Trouble When Exercising COVID-19 Update: What We Know and the Answers We Seek The Intersection of Autoimmune Diseases and the Lung Making Strides in the Treatment of Cystic Fibrosis Big Impact Ideas: Our Next Life-Changing Discoveries Want to use this on your website? Fill out the content usage request form and then copy this code: